Latest Innovation News

RMA Global Limited reveals its strategic push into the US market, leveraging its Local Expert Marketing platform to capture a significant share of the real estate marketing sector.

Terragen Holdings has received nearly $1 million in R&D tax incentives, reinforcing its cash position and fueling ongoing development of its innovative agricultural biotech products.

Identitii Limited has announced a pro rata non-renounceable rights issue to raise approximately $2.88 million, partially underwritten by Beauvais Capital Pty Ltd. The funds will support the development and commercialisation of its BNDRY platform amid ongoing patent litigation risks.

Identitii Limited launches a $2.9 million rights issue, underwritten up to $2.3 million by its largest shareholder, to accelerate the commercial rollout of its BNDRY platform.

Anteris Technologies has secured regulatory green lights for its pivotal PARADIGM trial and raised $25.2 million in capital, advancing its innovative DurAVR® transcatheter heart valve towards commercialisation.

BetMakers Technology Group has inked a pivotal five-year exclusive agreement with Betfair Australia to provide the full wagering technology stack for CrownBet's launch, marking a major milestone for its Apollo platform.

HITIQ Limited has successfully raised $925,000 through an oversubscribed placement, issuing shares at a discount and attaching listed options to support its concussion management technology's commercialisation.

Volt Resources has initiated a Definitive Feasibility Study for its Alabama Graphite Refinery, aiming to produce high purity graphite by mid-2026 and strengthen US critical minerals supply chains.

AdNeo Limited’s recent acquisition, Aspire by Catapult, has won a significant $148,000 contract to develop Australia’s inaugural Advanced Diploma in Digital Innovation, marking a strategic expansion in the vocational education sector.

InhaleRx has boosted its funding facility by $12.6 million to accelerate clinical trials of SRX-25, a novel oral treatment for Treatment-Resistant Depression. This brings total available capital to $52.3 million, positioning the company for pivotal Phase III studies.

BrainChip Holdings has closed its Share Purchase Plan with subscriptions exceeding the $2 million target by nearly $1 million, complementing a recent $35 million placement. The Board’s decision to accept all applications reflects robust shareholder confidence.

St George Mining’s Araxá Project in Brazil gains significant government and community support, highlighting its potential as a world-class rare earths and niobium resource with sustainable mining at its core.